Atreca, Inc. Uncategorized Contracts & Agreements
12 Contracts & Agreements
- Form of Support Agreement, dated as of December 22, 2023, by and among Atreca, Inc. Immunome, Inc and the person set forth on Schedule A thereto (Filed With SEC on December 26, 2023)
- Form of RSU Grant Notice and Award Agreement for Atreca, Inc. 2023 Inducement Plan (Filed With SEC on March 29, 2023)
- Atreca, Inc. 2023 Inducement Plan (Filed With SEC on March 29, 2023)
- Amendment No. 2 to Exclusive (Equity) Agreement, dated as of July 2, 2020, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University (Filed With SEC on March 3, 2022)
- Description of Registrants Securities (Filed With SEC on March 11, 2020)
- Letter Agreement, dated as of November 7, 2019, by and between the Registrant and Susan Berland (Filed With SEC on November 12, 2019)
- Letter Agreement, dated May 28, 2019, between the Registrant and Lisa Decker (Filed With SEC on August 13, 2019)
- Amendment to the Exclusive (Equity) Agreement, dated as of May 24, 2018, by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University (Filed With SEC on June 10, 2019)
- Exclusive (Equity) Agreement, dated as of June 28, 2012, by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University (Filed With SEC on June 10, 2019)
- Nominating Agreement, dated as of September 5, 2018, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P (Filed With SEC on June 10, 2019)
- Letter Agreement, dated as of August 21, 2015, by and between the Registrant and the Bill & Melinda Gates Foundation (Filed With SEC on June 10, 2019)
- Form of Indemnity Agreement entered into by and between Atreca, Inc. and each director and executive officer (Filed With SEC on May 24, 2019)